Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biomarkers in Toxicology / / edited by Vinood B. Patel, Victor R. Preedy, Rajkumar Rajendram
| Biomarkers in Toxicology / / edited by Vinood B. Patel, Victor R. Preedy, Rajkumar Rajendram |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (1160 pages) |
| Disciplina |
610.28
615.9 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Biochemical markers
Toxicology Medicine—Research Biology—Research Pharmacology Forensic sciences Biomarkers Medical Toxicology Biomedical Research Forensic Science |
| ISBN | 3-031-07392-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Markers of liver toxicity and biomarkers -- Biomarkers of kidney toxicity. -Biomarkers of cardiac toxicity: microRNA and beyond.-Biomarkers of gastrointestinal toxicity -- Biomarkers of skin toxicity -- Skeletal muscle biomarkers in toxicity studies -- Bone markers of toxicity -- biochemical markers of brain damage -- DNA adducts as biomarkers of nutritional toxicity -- Biomarkers of pollution toxicity: measuring heavy metals in blood -- Challenge-comet assay: applications to toxicity -- Alkylation adducts of nucleic acids as a biomarkers .-TGx-DDI transcriptomic biomarker: Features and applications.-DNA biomarkers: an updated narrative -- CRISPR/Cas9 Whole-Genome Screens: applications to environmental pollutants.-Apoptotic biomarkers in toxicity studies -- 5'UTR methylation as a biomarkers: investigating volatile organics -- 5-Fluorouracil degradation rate and a biomarker of capecitabine toxicity -- Investigating the blood-brain barrier as a marker of toxicology -- Biomarkers of oxidative stress: investigating apigenin -- Histology as a biomarker in toxicity: applications to investigating Syzygium guineense -- Hair metabolomics and biomarker discovery .-Markers of hepatotoxicity using metabolomics: applications to MDMA, ecstasy -- 1H-NMR metabolomics and biomarkers of myotoxins -- Nanoparticle-induced toxicity and transcriptomics as a biomarker discovery platform -- Urine metabolomics and biomarker discovery.-microRNA profiling as a biomarker platform: carcinogens and beyond. |
| Record Nr. | UNINA-9910647783003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Data Monitoring Committees (DMCs) : Past, Present, and Future / / edited by Nand Kishore Rawat, David Kerr
| Data Monitoring Committees (DMCs) : Past, Present, and Future / / edited by Nand Kishore Rawat, David Kerr |
| Autore | Rawat Nand Kishore |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (113 pages) |
| Disciplina | 615.50724 |
| Altri autori (Persone) | KerrDavid |
| Soggetto topico |
Pharmacology
Medical sciences Drug development Medicine—Research Biology—Research Pharmaceutical chemistry Biometry Toxicology Preclinical Research Biomedical Research Pharmaceutics Biostatistics Medical Toxicology |
| ISBN | 3-031-28760-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction-.What is a DMC?-. Is a DMC required?-. Who is On the DMC?-. What are the Legal and Ethical Aspects of DMC?-. How does the DMC work with SDAC and Sponsor and External Groups ? -- What Does a DMC Meeting Look Like -- What data is used for DMC outputs and who programs? -- What is Included in DMC Outputs? -- What does the DMC final DMC outputs look like and how is it delivered? -- What Types of Safety Outputs Does the DMC Receive? -- What types of efficacy outputs does the DMC receive? -- What types of other outputs does the DMC receive? -- What About In-Between DMC Meetings -- What types of formal interim analyses does the DMC review? -- What does the paperwork from meetings look like? -- How does the DMC assess risk-benefit for their decision making? -- What are some examples? -- Conclusions. |
| Record Nr. | UNINA-9910731469703321 |
Rawat Nand Kishore
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Disaster Medicine Pocket Guide: 50 Essential Questions : Work of the French Society of Disaster Medicine / / edited by Henri F Julien
| Disaster Medicine Pocket Guide: 50 Essential Questions : Work of the French Society of Disaster Medicine / / edited by Henri F Julien |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (242 pages) |
| Disciplina | 362.18 |
| Soggetto topico |
Emergency medicine
Psychiatry Toxicology Emergency Medicine Medical Toxicology Medicina de catàstrofes Medicina d'urgència |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
9783031006548
9783031006531 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. Introduction to disaster medicine -- Chapter 1. Disaster, uncommon health crises, and disaster medicine -- Chapter 2. Ethics, deontology in disasters -- Chapter 3. Medico-legal issues.-Chapter 4. Doctors and media in disasters -- Part II. Organising Healthcare and emergency actions -- Chapter 5. ORSEC-NOVI plan -- Chapter 6. Contingency plan, uncommon health crises (UHC) -- Chapter 7. Emergency chain in disaster medicine -- Chapter 8. Medical Emergency Director (MED) -- Chapter 9. First doctor on disaster scene -- Chapter 10. Role of the medical manager of intra-hospital crisis -- Chapter 11. Triage of disaster medicine -- Chapter 12. Advanced medical posts (AMP) -- Chapter 13. Casualty collection point (CCP) -- Chapter 14. Rescue in shooting and hostages-taking -- Chapter 15. Medical coverage of big crowds -- Part III. Disastrous events -- Chapter 16. Destructive earthquakes -- Chapter 17. Cyclones -- Chapter 18. Volcanic eruptions -- Chapter 19. Cold waves -- Chapter 20. Heat waves -- Chapter 21. Disasters and epidemics -- Chapter 22. Dwellings fires -- Chapter 23. Fire smoke inhalation -- Chapter 24. Explosions -- Chapter 25. Nuclear and radiological accidents -- Chapter 26. Traffic accidents involving many victims -- Chapter 27. Railway accidents -- Chapter 28. Warfare chemical agents -- Chapter 29. Forest fires -- Part IV Techniques of disaster medicine -- Chapter 30. Principles of field medical care -- Chapter 31. Medical dispatch in crises and disasters -- Chapter 32. Crush syndrome -- Chapter 33. Blast -- Chapter 34. Ballistic wounds: management principles -- Chapter 35. Damage control -- Chapter 36. Fluid therapy in disasters -- Chapter 37. Procedural sedation and analgesia -- Chapter 38. Search and rescue (SAR) -- Chapter 39. Life-saving amputation -- Chapter 40. Disaster situations and psychological impact -- Chapter 41. Reception of CoVID-19 patients at the ER -- Chapter 42. Mass casualty decontamination -- Chapter 43. Emergency dry decontamination -- Chapter 44. Children and disasters -- Chapter 45. Pharmaceutical preparedness in disaster medicine -- Chapter 46. Antidotes for chemical and radiological agents -- Chapter 47. Mobile medical post (MMP) -- Chapter 48. PPE of health staff -- Chapter 49. FMC, SINUS, and patient tracking in disasters -- Chapter 50. Transmission in disasters. |
| Record Nr. | UNINA-9910619286003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomaterial-Based Drug Delivery Systems : Therapeutic and Theranostic Applications / / edited by Chandrakantsing V. Pardeshi
| Nanomaterial-Based Drug Delivery Systems : Therapeutic and Theranostic Applications / / edited by Chandrakantsing V. Pardeshi |
| Autore | Pardeshi Chandrakantsing V. |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (415 pages) |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical chemistry
Nanomedicine Toxicology Pharmacology Pharmaceutics Nanomedicine and Nanotoxicology Medical Toxicology |
| ISBN | 3-031-30529-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section-I: Introduction to nanomaterials for drug delivery -- Introduction to Nanomaterials for drug delivery -- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications -- Polymer-based nanomaterials -- Lipid-based nanomaterials -- Vesicular nanomaterials -- Hybrid nanomaterials -- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications -- Magnetic nanoparticles -- Quantum dots -- Upconversion nanoparticles -- Gold nanoparticles -- Carbon-based nanoparticles -- Graphene-based nanoparticles -- Section-IV: Nanomaterials toxicity & clinical translation -- Nanotoxicology: an overview -- Patenting nanomaterials: Regulatory aspects -- Clinical perspectives: Translating nanomaterials from laboratory to clinic. |
| Record Nr. | UNINA-9910734885903321 |
|
Pardeshi Chandrakantsing V.
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Persistent Organic Pollutants in Human Milk [[electronic resource] /] / edited by Rainer Malisch, Peter Fürst, Kateřina Šebková
| Persistent Organic Pollutants in Human Milk [[electronic resource] /] / edited by Rainer Malisch, Peter Fürst, Kateřina Šebková |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (XXVII, 683 p. 318 illus., 309 illus. in color.) |
| Disciplina | 577.14 |
| Soggetto topico |
Environmental chemistry
Analytical chemistry Toxicology Gynecology Nutrition Environment Environmental Chemistry Analytical Chemistry Medical Toxicology Environmental Sciences |
| ISBN | 3-031-34087-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I Introduction -- Chapter 1 Human milk surveys on persistent organic pollutants from a historical perspective -- Chapter 2 Overview of WHO- and UNEP-coordinated human milk studies and their link to the Stockholm Convention on persistent organic pollutants -- Chapter 3 The Stockholm Convention, Global Monitoring Plan and its implementation in regional and global monitoring reports -- Part II Analytical methods and quality control -- Chapter 4 Analysis and quality control of WHO- and UNEP-coordinated human milk studies 2000–2019: polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans -- Chapter 5 Analysis and quality control of WHO- and UNEP-coordinated human milk studies 2000–2019: organochlorine pesticides and industrial chemicals -- Chapter 6 Analysis and quality control of WHO- and UNEP-coordinated human milk studies 2000–2019: polybrominated diphenylethers, hexabromocyclododecanes, chlorinated paraffins and polychlorinated naphthalenes -- Part III WHO/UNEP-coordinated exposure studies 2000–2019: results of chlorinated and brominated POPs and discussion -- Chapter 7 WHO- and UNEP-coordinated human milk studies 2000–2019: findings of polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans -- Chapter 8 WHO- and UNEP-coordinated human milk studies 2000–2019: findings of organochlorine pesticides and industrial chemicals -- Chapter 9 WHO- and UNEP-coordinated human milk studies 2000–2019: findings of polybrominated substances (PBDE, HBCDD, PBB 153, PBDD/PBDF) -- Chapter 10 WHO- and UNEP-coordinated human milk studies 2000–2019: findings of chlorinated paraffins -- Chapter 11 WHO- and UNEP-coordinated human milk studies 2000–2019: findings of polychlorinated naphthalenes -- Part IV Assessments -- Chapter 12 Time trends in human milk derived from WHO- and UNEP-coordinated exposure studies; Chapter 1: polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans -- Chapter 13 Time trends in human milk derived from WHO- and UNEP-coordinated exposure studies; Chapter 2: DDT, beta-HCH and HCB -- Chapter 14 Time trends in human milk derived from WHO- and UNEP-coordinated exposure studies; Chapter 3: perfluoroalkyl substances (PFAS) -- Chapter 15 Risk-benefit analysis for the breastfed infant based on the WHO- and UNEP human milk surveys for dioxin-like compounds -- Part V Summary, conclusions and outlook -- Chapter 16 Overall conclusions and key messages of the WHO/UNEP-coordinated human milk studies on persistent organic pollutants -- Chapter 17 Outlook (towards future studies on human milk). |
| Record Nr. | UNINA-9910746981703321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Medical Toxicology
(5)
- Toxicology (5)
- Pharmacology (3)
- Biology—Research (2)
- Biomedical Research (2)